This study is testing a new medicine, MK-1167, for Alzheimer's Disease (AD) dementia. Alzheimer's is a condition that affects memory and thinking. The study wants to find out if MK-1167 helps improve these symptoms when used with another treatment called acetylcholinesterase inhibitor (AChEI) therapy, which is a usual treatment for AD dementia. Researchers will also see if MK-1167 is safe and if people can handle it well.
Who Can Join?
- People with mild or moderate AD dementia.
- Participants need a partner to help with the study.
- Participants must be on AChEI therapy.
Who Cannot Join?
- People with other brain diseases or major health problems.
- Anyone with a history of stroke, seizures, or liver disease.
- Residents in nursing homes needing constant care.
Things to Know:
- The study will compare MK-1167 to a placebo (a fake treatment).
- Participation involves checking how well the medicine works and any side effects.
- Participants must have someone with them who knows them well to help with the study.
How understandable was the trial content above?
Hard to understand
Easy to understand